meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Chemotherapy (CT)-induced Cardiotoxicity
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Chemotherapy-induced cardiotoxicity refers to heart damage resulting from cancer treatment, particularly the use of specific chemotherapy drugs or targeted therapy drugs, as well as chest radiation therapy. This condition can manifest as functional or structural cardiac injury and includes a range of cardiac problems, including myocardial injury, left ventricular dysfunction (LVD), cardiomyopathy, and heart failure (HF). It also affects other cardiac structures, such as the pericardium, valves, and coronary arteries.
Chemotherapy-induced cardiotoxicity can be classified into acute or subacute types and may be due to various mechanisms, including [reactive oxygen species…
References (Sources)
- Chemotherapy-Induced Cardiotoxicity in Cancer Treatment: Mechanisms and Its Prevention
- Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs
- Monitoring for Chemotherapy-Related Cardiotoxicity in the Form of Left Ventricular Systolic Dysfunction: A Review of Current RecommendationsReview